Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis.

Pediatric Blood & Cancer
Mathilde TardieuJean Donadieu

Abstract

The somatic BRAFV600E mutation occurs in 38-64% of pediatric cases of Langerhans cell histiocytosis (LCH). Vemurafenib (VMF), a BRAF inhibitor, was approved for refractory BRAFV600E mutated LCH. In adults, VMF causes frequent cutaneous adverse events (CAE) including skin tumors (squamous cell carcinomas, melanomas), but little is known in children. The objective of this study was to evaluate the frequency, clinical spectrum, and severity of CAEs in children treated with VMF for LCH. In addition, a correlation between CAE occurrence and VMF dose, residual plasma levels (RPLs), and efficacy was searched for. Multicentric retrospective observational study including patients <18 years treated with VMF alone for refractory BRAFV600E mutated LCH in 13 countries between October 1, 2013 and December 31, 2018. Fifty-seven patients: 56% female, median age 2.1 years (0.2-14.6), median treatment duration 4.1 months (1.4-29.7). Forty-one patients (72%) had at least one CAE: photosensitivity (40%), keratosis pilaris (32%), rash (26%), xerosis (21%), and neutrophilic panniculitis (16%). No skin tumor was observed. Five percent of CAEs were grade 3. None were grade 4 or led to permanent VMF discontinuation. Dose reduction was necessary for 12%...Continue Reading

References

Apr 29, 1999·The New England Journal of Medicine·B A GilchrestM Yaar
Jun 4, 2010·Blood·Gayane Badalian-VeryBarrett J Rollins
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A OberholzerLevi A Garraway
Jan 20, 2012·The New England Journal of Medicine·Fei SuRichard Marais
Feb 3, 2012·The New England Journal of Medicine·Reinhard DummerSimone M Goldinger
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa ZimmerDirk Schadendorf
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Feb 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BoussemartC Robert
Mar 5, 2013·The Oncologist·Mario E LacoutureAndrew K Joe
Mar 22, 2013·PloS One·Jeannine D RinderknechtBenedetta Belloni
Apr 19, 2013·Pathology·Sahar PakneshanAlfred King-Yin Lam
Dec 7, 2013·The Journal of Investigative Dermatology·Marie Perier-MuzetStephane Dalle
Jan 1, 2014·Pediatric Blood & Cancer·Francisco BautistaBirgit Geoerger
Mar 8, 2014·Pediatric Dermatology·Emily S WestJoseph G Morelli
Mar 19, 2014·The Journal of Experimental Medicine·Marie-Luise BerresCarl E Allen
May 13, 2014·Journal of Pharmaceutical and Biomedical Analysis·Jean-Claude AlvarezAdeline Knapp
Sep 2, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·A GeyT Jouary
Dec 20, 2014·Journal of Translational Medicine·Francesca del BufaloAngela Mastronuzzi
Mar 11, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·R MössnerS Ugurel
Jun 19, 2015·Journal of the National Comprehensive Cancer Network : JNCCN·Letizia GandolfiPier Luigi Zinzani
Jul 17, 2015·JAMA Oncology·Sébastien HéritierJean Donadieu
Nov 3, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·L PeuvrelB Dréno
Nov 19, 2015·Pediatric Blood & Cancer·Dolly AguileraTobey J MacDonald
Mar 10, 2016·The American Journal of Dermatopathology·Igor Vázquez-OsorioHugo Vázquez-Veiga
Apr 5, 2016·Dermatology Research and Practice·Bilgen Gençler, Müzeyyen Gönül
Jun 22, 2016·Expert Opinion on Drug Discovery·Alex Kim, Mark S Cohen
Feb 3, 2018·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Santhosh A UpadhyayaIbrahim A Qaddoumi
Mar 27, 2018·Pediatric Dermatology·Trisha BhatCarrie C Coughlin
Aug 30, 2018·The New England Journal of Medicine·Carl E AllenKenneth L McClain
Nov 27, 2018·Pediatric Dermatology·Olivia S JewJames R Treat
Sep 13, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean DonadieuSébastien Héritier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.